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Over the last several years, there has been signiﬁcant advancement in the molecular characterization of intracranial diseases,
particularlycerebralneoplasms.Whilenuclearmedicinetechnology,includingPET/CT,hasbeenattheforegroundofexploration,
new MR imaging techniques, speciﬁcally diﬀusion-weighted and diﬀusion tensor imaging, have shown interesting applications
towards advancing our understanding of cancer involving the brain. In this paper, we review the fundamentals and basic physics
of these techniques, and their applications to patient care for both general diagnostic use and in answering speciﬁc questions in
selection of patients in terms of expected response to treatment.
1. DiffusionMR Imaging:
FundamentalsandPhysics
Diﬀusion magnetic resonance imaging (MR) utilizes the
Brownian motion of molecules to derive images. Robert
Brown ﬁrst described the motion bearing his name in
1827 [1] after observing the random motion of pollen
grains suspended in water. Movement caused by the random
movements of water molecules has endlessly fascinated
scientists, even Einstein, who in 1907 speculated that the
speed of the particles subject to Brownian motion would be
dependent only on temperature, and not on the size and
nature of the particle or on its environment [2]. Einstein
speculated that this prediction would be impossible to verify
experimentally due to the technical challenges involved in
taking measurements on extremely short time scales and
microscopic spatial scales. Recent work though, using laser
tweezers to measure a silicon dioxide microsphere’s motion
in air, has measured instantaneous velocities of the particle
following a Maxwell-Boltzmann distribution; a mean square
displacement velocity of 0.422mm/s has been determined
[3]. However, the technical demands for such measurements
in water rather than air are still beyond current technical
capabilities, conﬁrming Einstein’s prediction after more than
a century. This primal kinetic activity of ﬂuid molecules
is responsible for the diﬀusion and intermixing of ﬂuids
and dissolved substances and is the process targeted for
measurement with diﬀusion MR imaging. Through carefully
designed MR sequences, much can be learned about the dif-
fusion of water molecules, and by implication, the structure
of the organ or substrate the water is in.
In MR imaging, the local magnetic ﬁeld determines the
rate of precession, or wobbling, of hydrogen nuclei. With
diﬀusion MR imaging, a gradient is applied and precession
is induced by an applied radiofrequency pulse. The gradient
is then reversed and an equal and opposite radiofrequency
pulse applied. The purpose of this is to “null” or decrease the
signal from the stationary protons, while the mobile protons,
whichhavechangedpositionduringtimeperiodbetweenthe
two radiofrequency pulses, will not be nulled perfectly.
Measuring the signal of the mobile protons allows deter-
mination of the amount of diﬀusion which has occurred,
and this is represented as a mathematical equation. By rear-
ranging this mathematical equation to isolate the diﬀusion
coeﬃcient, information about diﬀu s i o nw i t h i ne a c hv o x e l
canbeobtained.Themagnitudeofdiﬀusionwithinthevoxel
is measured by the Apparent Diﬀusion Coeﬃcient (ADC),
a n dt h i si n f o r m a t i o nc a nb eu s e dt oc r e a t ea ni m a g ec a l l e d
an ADC map. A low value for ADC indicates that molecular
movement in the sampled tissue is restricted (dark signal),2 International Journal of Molecular Imaging
while a high value for ADC indicates that the tissue has free
diﬀusion (bright signal).
1.1. Application: Stroke. Some of the earliest applications of
diﬀusion-weighted imaging (DWI) in humans were to diag-
nose cerebral infarction [4]. It was found that ADC values
dropped quickly after infarction, with a nadir reached at
about 24 hours, and that infarcts could be diagnosed earlier
ontheDWIsequencethanonT2-weightedimages.Diﬀusion
imaging rapidly became the new standard of imaging care in
stroke and was soon augmented by perfusion-based imaging
strategies [5].
The mechanism of why stroke shows restricted diﬀusion
of water is still unclear, but is thought to be due to ischemia
causing failure of the ionic pumps which usually maintain
ion gradients across the cell membrane; water then diﬀuses
into the cells, which become swollen. This net shift of water
from the extracellular environment, where it can diﬀuse
relatively freely, to the intracellular environment, where dif-
fusion is relatively restricted, is thought to be the mechanism
for restricted diﬀusion. It also explains the transient nature
of the ADC abnormality, as the cytotoxic cells eventually
lyse; this rupture and destruction of organized matrix
again lets water molecules diﬀuse freely. ADC typically
returns to normal as the infarct evolves to encephalomalacia
[6].
When evaluating for acute ischemic stroke, one ﬁrst
interprets the trace DWI sequence, looking for signal
hyperintensity. A limitation of the DWI sequence is that it
is sensitive, but not speciﬁc for the detection of restricted
diﬀusion. If there is signal hyperintensity present on a rou-
tine T2-weighted images, such as from cytotoxic edema, this
signal hyperintensity may be present on the DWI sequence,
an eﬀect referred to as “T2 shine-through”. To determine if
the signal hyperintensity seen on the DWI sequence truly
representsdecreaseddiﬀusion,anADCsequenceisreviewed.
The ADC sequence is not as sensitive as the DWI sequence
for restricted diﬀusion, but is more speciﬁc, as the ADC
images are not susceptible to the “T2 shine-through”e ﬀect.
Ischemic brain parenchyma will show a low ADC value and
associated edema will not. Therefore, an acute stroke will
have signal hyperintensity on the DWI sequence and low
signal intensity on ADC sequence (Figure 1).
1.2. Application: Diﬀusion Imaging in Abscess and Tumors.
As diﬀusion-weighted imaging provides information about
the mobility of water molecules in, for example, brain
parenchyma, tumors, pus, and cysts (Figure 2), it can be
classiﬁed as a type of molecular imaging [7]. Ebisu et al. [8]
ﬁrst reported high signal intensity of abscess pus on the DWI
sequence with a corresponding low ADC value consistent
with restricted diﬀusion (Figure 3).
Given that cell death seems to induce restricted diﬀusion
in stroke, there has been much interest in utilizing this prin-
ciple for imaging cancer, where cell death of the malignancy
is the desired therapeutic outcome. Several authors [9, 10]
have described that tumor cellularity is a major determinate
of ADC values in brain tumors. Solid tumors are generally
more water-rich than normal brain and are thus brighter on
T2-weighted images and have a higher ADC. Surrounding
edema, unfortunately shares these same attributes, making
the DWI sequence less valuable in the distinction of tumor
borders.
While diﬀusion-weightedimagingshowsrestricteddiﬀu-
sion in certain tumor types, such as epidermoid, lymphoma
(Figure 4), and primitive neuroectodermal tumor (PNET)
(Figure 5), the sequence has had limited success in grading
brain tumors, and in distinguishing between histological
s u b t y p e s .G u oe ta l .[ 9] reported a lower mean ADC value as
a relative aid in diﬀerentiating primary cerebral lymphoma
from high-grade astrocytoma. Rumboldt et al. [11] used
ADC maps to diﬀerentiate types of childhood tumors. They
found that ADC values were signiﬁcantly higher in pilocytic
astrocytomas than in ependymomas and medulloblastomas.
Diﬀusion imaging has been described in the evaluation
of cystic tumors; these tumors tend to show low signal on
the DWI sequence and high signal on the ADC sequence
[12–15]. However, this description may be confusing, as ring
enhancing metastasis of adenocarcinoma have been reported
with high signal on the DWI sequence and low signal on
the ADC sequence, mimicking restricted diﬀusion of an
abscess [16, 17]. Restricted diﬀusion has been described in
squamous cell carcinoma metastasis, radiation necrosis [18],
and glioblastomas [19]. Several studies demonstrate that
the ADC sequence can help diﬀerentiate primary cerebral
lymphoma (PCL) from high-grade gliomas [9, 10, 20–22],
and brain metastasis [10]f r o mP C L ;h o w e v e r ,o t h e rs t u d i e s
have reported overlap between these tumor types [23, 24].
The diﬀusion sequences should, therefore, be interpreting
with caution, and in the context of reviewing the entire MR
study and clinical history.
2. Diffusion Tensor Imagingand
White Matter Tracking
Diﬀusion tensor imaging (DTI) represents a further devel-
opment of diﬀusion-weighted imaging [25], investigating
more than just the diﬀusion coeﬃcient. DTI measures
both the direction and magnitude of proton movement
within the voxel for multiple dimensions of movement,
using a mathematical construct, the diﬀusion tensor, to
represent this information. Water in cerebrospinal ﬂuid in
a ventricle is essentially free to diﬀuse unimpeded in all
directions and would be represented as a sphere. Water
molecules along the axons of white matter tracts are in
a highly structured environment and thus the diﬀusion
becomes highly directional along the length of the tract
[26]. Displaying this type of structured diﬀusion would be
represented by an ellipsoid, or even multiple ellipsoids, if
more than one white matter tract were interdigitating.
Multiplewayshavebeendevisedtodisplaythesecomplex
datasets. One of the simpler methods is the Fractional
Anisotropy (FA) map, which is simply a measure of how
distorted the diﬀusion spheroid has become at the point of
measurement. A scalar value between 0 and 1 describes the
degree of anisotropy or restricted movement. A value closerInternational Journal of Molecular Imaging 3
(a) (b)
Figure 1: A 76-year-old female with history of acute myelogenous leukemia and atrial ﬁbrillation, presenting with altered mental status
related to embolic stroke. (a) DWI sequence. (b) ADC map. Areas of signal hyperintensity on the DWI sequence (arrows) are conﬁrmed to
represent restricted diﬀusion by the signal hypointensity on the ADC map (arrows).
(a) (b) (c)
Figure 2: A 32-year-old man with a metastatic melanoma with an incidentally detected left cerebellopontine angle arachnoid cyst. (a) Axial
Fast Spin Echo T2 sequence. T2 hyperintensity is seen in the cerebellopontine angle mass (arrow). (b) DWI sequence. The mass is dark
on diﬀusion-weighted imaging. (c) ADC map. Signal hyperintensity in the lesion on the ADC map (arrow) is present. These ﬁndings are
consistent with a cyst and exclude other lesions such as an epidermoid.
to 0 is assigned if the voxel is spherical, and a value near 1,
if the voxel is an ellipsoid tending to a line. In other words,
the value of 0 means that diﬀusion is isotropic, that is, it is
unrestricted or free to move in all directions. A value of 1
means that diﬀusion occurs along a single axis, that is, not
free to move in other directions. Therefore, white matter,
which has diﬀusion ellipsoids oriented along the course of
ﬁber tracts, has a high FA value, whereas cerebrospinal ﬂuid
has low FA values, indicative isotropic diﬀusion [7].
FA has been used in the study of brain neoplasms [24,
27]. However, in contrast to ADC, the relationship between
FA and cellularity has not been substantiated [21]. Toh et
al. [22] reported signiﬁcantly decreased FA values in highly
cellular PCL compared with glioblastomas, while Kinoshita
et al. [28] demonstrated high FA values in the PCLs in their
series. Further study is needed in this area.
More sophisticated measures involve the use of color
coding to communicate and display information about the4 International Journal of Molecular Imaging
(a) (b) (c)
Figure 3: A 19-year-old man presented with diplopia and left-sided weakness, and a right thalamic abscess. (a) Axial T1 postcontrast. A
ring enhancing mass is present in the right thalamus (arrow). (b) DWI sequence. Signal hyperintensity is present in the lesion (arrow). (c)
ADC map. Signal hypointensity in the lesion (arrow) conﬁrms decreased diﬀusion. In the appropriate clinical context, this constellation of
ﬁndings is consistent with a pyogenic abscess.
(a) (b) (c)
Figure 4: A 63-year-old female with diﬀuse large B-cell lymphoma involving the frontal and parietal lobes. (a) Axial T1 postcontrast.
Diﬀusely enhancing right cerebral mass lesions are present (white arrows). (b) DWI sequence. The lesions are hyperintense on diﬀusion-
weighted imaging (white arrows). (c) ADC map. The ADC map shows hypointensity of the lesions (dark arrows).
direction of white matter tracts. Typically, one color will
encode the front-to-back direction, and other will encode
colors the two other cardinal directions (Figure 6). The
colorful maps thus generated are very useful for portraying
the complexities of white matter anatomy more faithfully
than possible with FA maps alone. Given that diﬀusion
anisotropy and white matter structure are tightly linked, it
makes sense that white matter tracts could be mapped with
this information [29].
Having knowledge of the dominant vectors (eigenvec-
t o r s )o fd i ﬀusion for a particular voxel allows one to use
these as input values for probabilistic algorithms. Such an
a l g o r i t h m ,g i v e nas e e d p o i n ti nac e r e b r a ld i ﬀusion map,
will be able to propagate itself through the space in a
manner that might closely approximate the true anatomy
of white matter tracts. Such methods are useful, and
frequently combined with functional MR images to provide
surgical guidance during surgeries near eloquent brain.International Journal of Molecular Imaging 5
(a) (b) (c)
Figure 5: A 2-year-old female with a left parietal primitive neuroectodermal (PNET), WHO grade IV. (a) Axial T1 postcontrast. A faintly
enhancing left parietal lobe mass is present (arrows). (b) DWI sequence. The mass is hyperintense on diﬀusion-weighted imaging. (c) ADC
map. Signal hypointensity of the lesion on the ADC map (arrow) is present, consistent with restricted diﬀusion related to dense cell packing.
(a) (b)
Figure 6: A 41-year-old woman with a right frontal lobe glioblastoma. (a) Axial T1 postcontrast. A centrally necrotic, ring enhancing mass
is present in the posterior right frontal lobe (arrow). (b) Axial diﬀusion tensor image. The mass causes medial displacement of adjacent
corticospinal tract (arrow) comparison is made to the contralateral side. Color-coded nomenclature is present in the right lower corner.
These imaging methods have proven a very useful adjunct to
intraoperative surgical stimulation. However, these methods
have signiﬁcant shortcomings when complex tracts cross
through each other, and more sophisticated methods of
navigating using these principles are under development
[30, 31].
2.1. Application: Surgical Planning. The goal of brain tumor
resection is to remove the maximal amount of tumor
while preserving vital portions of brain. Diﬀusion tensor
imaging allows mapping of whitematter tracts and their
relation to tumors can be demonstrated preoperatively.
This can assist the neurosurgeon in planning the most
appropriate approach to the tumor, maximizing the amount
of tumor resected, and avoid vital structures, such as the
corticospinal tract. The white matter tracts in the involved
hemisphere can then be compared to the contralateral side,
to determine the degree of displacement (Figure 6). Several
sites in the United States have an MRI unit in the operative
suite; this allows intraoperative imaging, including DTI.
A recent report by Nimsky et al. describes the success of
this technique in localization of shifting white matter tracts
during neurosurgical procedures [32].6 International Journal of Molecular Imaging
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Figure 7: The use of ACD histograms in the analysis of cerebral malignancies. (a) Total enhancing tumor volume was segmented on axial
postcontrast T1-weighted images in a 52-year-old woman with recurrent GBM and transferred to (b) the corresponding ADC map image
for generation of ADC histogram (c, d). (c) A single distribution-ﬁtted curve provided a poor ﬁt of the data, which could be substantially
improved by using (d) a two-component normal mixture model (From [33]) Reprinted with permission.
3.ADC HistogramAnalysis
3.1. Technique. The technique of calculating the ADC coef-
ﬁcient for a given volume on a voxel by voxel basis for
histogram analysis has been described by several authors
[33–35]. Important diﬀerences exist between ADC analyses
of these authors. Pope et al. [33, 34]u s e dA D Cv a l u e sf r o m
regions of interest corresponding to the enhancing portion
of the tumor only; they excluded regions of nonenhancing
T2-weighted signal hyperintensity, which represent edema
and/or inﬁltrative tumor [33, 34]; Murkami et al. [35]
included these regions of T2 signal hyperintensity in their
analysis.
3.2. Application: Predicting Glioblastoma Response to Beva-
cizumab (Avastin) Treatment and Progression-Free Survival
in Bevacizumab-Treated Glioblastoma. Vascular endothelial
growth factor (VEGF) and its receptors are highly expressed
in glioblastomas [36], an aggressive cerebral neoplasm.
VEGF is a potential mediator of cerebrovascular permeabil-
ity, hypothesized to promote new blood vessel formation
as well as transformation into a more aggressive phenotype
[37, 38].
Bevacizumab is a monoclonal antibody that targets
VEGFandpreventsitbindingtoitstyrosinekinasereceptors.
Inhibiting the VEGF pathway improves survival in patients
with glioblastoma multiforme (GBM) [39, 40]. However,
the response is variable and there is no way to predict how
patients will respond. Variable expression of VEGF could be
related to the mixed response to bevacizumab. In regions
of high cell density surrounding the necrotic areas, VEGF
is upregulated [41]. Diminished enhancement and edema,
apparently related to inhibition of vessel permeability by
VEGF, result from treatment with bevacizumab [42].
Necrosis caused by therapy or tumor growth degrades
cellular integrity and is thought to increase the ADC of tissue
[42, 43]. This is in contradistinction to areas of high cell
density, where the ADC is low, since water molecules are
more restricted in their movement within cells compared
to the extracellular space [44, 45]. The ADC has been used
to assess brain tumor response to therapy [45, 46]a n d
to predict survival in patients with newly diagnosed GBM
[35, 47, 48].
Pope et al. [33]hypothesizedthatbevacizumabtreatment
is more eﬀective in a necrotic tumor. Utilizing the aforemen-
tionedtechnique,theycalculatedtheADConavoxelbyvoxelInternational Journal of Molecular Imaging 7
basis for over the enhancing portion of the tumor mass and
generated a histogram curve. Two peaks were present in the
histogram curve analysis, and mean values were calculated
for the lower (ADCL) and upper peaks (ADCH), and average
ADC (Figure 7). Tumors were separated by using a cut-oﬀ
for mean ADCL of 1200 10−6 mm2/sec. Tumors with ADCL
less than 1200 10−6 mm2/sec were referred to as “low ADC
t u m o r s ” ,w h e r e a st u m o r sw i t hm e a nA D C L value greater or
equal to 1201 10−6 mm2/sec were referred to as “high ADC
tumors”. The low ADC component is thought to represent
tumors with tightly packed cells and minimal edema. This
is in contradistinction to the high ADC component which
may represent viable and necrotic tumor cells and associated
edema.
Pope et al. [33] found that bevacizumab extends
progression-free survival in patients with recurrent glioblas-
toma by a greater degree, if a high ADCL is present in
the enhancing portion of the tumor. The authors speculate
that the higher ADCL component might be related to
intratumoral necrosis, as patients with a higher necrotic
component seemed to beneﬁt most from bevacizumab.
In a second study, Pope et al. [34] found for patients
treated initially with bevacizumab, a lower ADCL was
associated with longer progression-free survival compared to
high ADCL. More research is clearly required, but there are
tantalizing indications that diﬀusion MR might be helpful in
stratifying patients into clinical risk groups and predicting
the outcomes of therapies. Further indications are that
patients with signiﬁcantly low ADC components on their
histograms may be overexpressors of O 6-methylguanine
methyltransferase (MGMT), a DNA repair mechanism that
imparts sensitivity to temozolomide, a standard therapeutic
in brain tumor therapy [34].
4. Conclusion
This article presents an overview of the current state of
diﬀusion-weighted and diﬀusion tensor MR imaging of
the brain in patients with cancer. In acute stroke, DWI
demonstrates decreased diﬀu s i o ni nav a s c u l a rt e r r i t o r y
aﬀected by ischemia. Similarly, decreased diﬀusion is present
in the center of pyogenic abscesses and aids in the MR
diagnosis of a ring-enhancing cerebral mass. In addition,
tumors such as lymphoma and PNET also demonstrate
decreasing diﬀusion, adding valuable information to the
radiologist when formulating a diﬀerential diagnosis of a
cerebral mass lesion. There are also growing applications in
diﬀerentiatingtumorssuchasglioblastoma,primarycerebral
lymphoma, and metastasis. Diﬀusion tensor imaging helps
the neurosurgeon in planning the surgical approach to a
cerebral neoplasm by demonstrating the location of white
matter ﬁber tracts in relation to the tumor; intraoperatively
ﬁber tract displacement can be assessed. Of great interest is
the use of histogram analysis in patients with glioblastoma
to stratify patients into clinical risk groups and to predict
the outcomes of therapies. We anticipate that as research
continues, both diﬀusion-weighted and diﬀusion tensor MR
imaging will have an impact on both diagnosis as well as
treatment of this patient with cerebral neoplasms.
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